Insider trade

Director exercised or converted 23K GDRX derivative securities

Traded Dec 21, 2025 · Filed Dec 22, 2025

Goodrx HoldingsGDRX

23K
Derivative units

Why it stands out

Derivative exercise or conversion — not an open-market buy.

Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell

View the official recordSEC Form 4 — Statement of Changes in Beneficial Ownership

All the details

Dates, kept separate

Transaction date: Dec 21, 2025
Reporting period: Not applicable
Filed with the SEC: Dec 22, 2025

DirectorOption exercise

Context

Classification

option exercise

Code M — exercise or conversion of a derivative security

Planned / mechanical clue

Footnote references vesting of compensation awards

Only flagged when a footnote says so; never inferred

Source receipt

Record ID: 0001545591-25-000004

Filed / recorded

Dec 22, 2025, 9:20 PM UTC

Added to OQRO

Oct 7, 2026, 5:51 AM UTC

Parser

form4-xml-v2

Data quality

Verified: identifiers matched exactly

Issuer

GoodRx Holdings, Inc.

Issuer CIK

1809519

Ticker

GDRX

Reporting person

Kelly J. Kennedy

Relationship

Director

Security

Restricted Stock Unit

Table

Derivative (Table II)

Transaction date

Dec 21, 2025

Transaction code

M

Shares / units

23,149

Price per share

$0.00

Acquired / disposed

Disposed (D)

Shares owned after

23,149

Ownership form

Direct

Amendment

No

Footnotes from the filing

Each restricted stock unit represents a contingent right to receive one share of Class A common stock.
The restricted stock unit award vests as to one-third of the shares underlying the award on each of the first three anniversaries of the grant date, beginning on December 21, 2024, subject to the Reporting Person's continued service with the Issuer through the applicable vesting date.